← Leaderboards
Stephen W White
Cornell University Ithaca
$9,528,194
Attributed
$12,241,504
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$12,241,504 · 7
By mechanism
R01$10,294,865 · 4
T32$1,134,136 · 1
R21$513,500 · 1
P41$299,003 · 1
Top collaborators
- Taosheng Chen4 shared
- Andrew M Davidoff4 shared
- Kenneth N Kreuzer4 shared
- Richard Edward Lee4 shared
- Jun Yang4 shared
Most similar at Cornell University Ithaca
Same institution · by research overlap
- Jun-Lin Guan$23,852,828
- Joseph Schlessinger$6,698,799
- Michael L Goldberg$6,605,510
- Mariana Federica Wolfner$18,623,522
- Vivian Cody$3,696,539
Others in their field
Top investigators on “Structural Biology”
- David Heimbrook · Leidos Biomedical Research, Inc.$410,804,893
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$293,732,896
- Chanza Baytop · Westat, Inc.$271,217,917
- Dennis R. Burton · Scripps Research Institute$261,340,518
- Barton F Haynes · Duke University$238,103,542
- David R. Weir · University Of Michigan At Ann Arbor$224,198,827
Research focus
Structural BiologyIn VivoBaseProteinsStructureMolecularInhibitor/AntagonistEnzymesPathway InteractionsDesignX-Ray CrystallographyBinding SitesLeadMutationOrganismDrug DiscoveryInfectionSiteLaboratoriesPharmaceutical ChemistryProgramsSpecificityIn VitroBiochemistry
Grant awards (35)
Development of small molecules to target KDM4B$410,606
R01 · FY2021 · CA
Training in the Design and Development of Infectious Disease Therapeutics$212,784
T32 · FY2021 · AI · contact PI
Development of small molecules to target KDM4B$410,606
R01 · FY2020 · CA
Development of small molecules to target KDM4B$398,287
R01 · FY2019 · CA
Training in the Design and Development of Infectious Disease Therapeutics$199,168
T32 · FY2019 · AI · contact PI
Development of small molecules to target KDM4B$410,606
R01 · FY2018 · CA
Training in the Design and Development of Infectious Disease Therapeutics$193,292
T32 · FY2018 · AI · contact PI
Training in the Design and Development of Infectious Disease Therapeutics$174,657
T32 · FY2017 · AI · contact PI
Training in the Design and Development of Infectious Disease Therapeutics$181,122
T32 · FY2016 · AI · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential - r$387,209
R01 · FY2015 · AI · contact PI
Training in the Design and Development of Infectious Disease Therapeutics$173,113
T32 · FY2015 · AI · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential - r$387,209
R01 · FY2014 · AI · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential - r$363,977
R01 · FY2013 · AI · contact PI
Recombination and fork progression in bacteriophage T4$349,562
R01 · FY2013 · GM · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential - r$387,209
R01 · FY2012 · AI · contact PI
Recombination and fork progression in bacteriophage T4$362,380
R01 · FY2012 · GM · contact PI
Recombination and fork progression in bacteriophage T4$362,283
R01 · FY2011 · GM · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential$623,075
R01 · FY2010 · AI · contact PI
Recombination and fork progression in bacteriophage T4$381,634
R01 · FY2010 · GM · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential$614,066
R01 · FY2009 · AI · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential$598,667
R01 · FY2008 · AI · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential$589,007
R01 · FY2007 · AI · contact PI
Recombination and fork progression in bacteriophage T4$347,947
R01 · FY2007 · GM · contact PI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential$601,071
R01 · FY2006 · AI · contact PI
Recombination and fork progression in bacteriophage T4$348,076
R01 · FY2006 · GM · contact PI
Recombination and fork progression in bacteriophage T4$346,247
R01 · FY2005 · GM
Development of DHPS as a Bioterrorism Therapeutic Target$249,500
R21 · FY2005 · AI
Recombination and fork progression in bacteriophage T4$348,839
R01 · FY2004 · GM
Development of DHPS as a Bioterrorism Therapeutic Target$264,000
R21 · FY2004 · AI
STRUCTURAL STUDIES ON RIBOSOMAL COMPONENTS$432,685
R01 · FY2002 · GM
MULTIWAVELENGTH ANOMALOUS DISPERSION DATA COLLECTION FROM E COLI FABH CRYSTALS$142,703
P41 · FY2002 · RR
STRUCTURAL STUDIES ON RIBOSOMAL COMPONENTS$421,997
R01 · FY2001 · GM
MULTIWAVELENGTH ANOMALOUS DISPERSION DATA COLLECTION FROM E COLI FABH CRYSTALS$142,703
P41 · FY2001 · RR
STRUCTURAL STUDIES ON RIBOSOMAL COMPONENTS$411,620
R01 · FY2000 · GM
MULTIWAVELENGTH ANOMALOUS DISPERSION DATA COLLECTION FROM E COLI FABH CRYSTALS$13,597
P41 · FY2000 · RR